Biofortis Research has announced that it will be participating in SupplySide West 2024, taking place in Las Vegas, NV on October 30 and 31st.
Biofortis Research (Addison, IL) has announced that it will be participating in SupplySide West 2024, taking place in Las Vegas, NV on October 30 and 31st. The company is showcasing its comprehensive suite of clinical study and consultancy services. According to the company’s news release, Biofortis has been in business for over 15 years and has completed 400 studies in that time, specializing in clinical studies for the food, supplement, and nutrition industries.
The company offers clinical studies targeting a wide range of outcomes, including cardiometabolic heath, glucose response, cognition, gastrointestinal, and sports nutrition. Biofortis also conducts clinical trials on safety/tolerance, bioavailability, appetite/satiety, and sensory perception. To conduct these studies, the company has a database of over 200,000 research integrated participants that allows for rapid recruitment, ensuring efficient and effective execution of clinical trials. On top of this, Biofortis also offers consulting services, including research commentary, evidence mapping, review of reviews, and meta-analysis, all led by its experienced PhD scientists.
“We are committed to advancing the science in the food, supplement, and nutrition industries,” said Chris Lancaster, Biofortis’s director of business development, in a press release. “We look forward to showcasing our expertise at SupplySide West helping our partners bring new and effective products to the market with confidence.”
The company’s team includes PhD nutrition scientists, experienced biostatisticians, on-site research physicians, and registered dietitians. Biofortis is part of Mérieux NutriSciences, which will be exhibiting at booth 2873 at SupplySide West. For appointments with Biofortis, you can reach out to Chris Lancaster at chris.lancaster@mxns.com.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.